-
Two innovative drugs are planned to be included in the priority review from Betta Pharmaceuticals and Cinda Bio
Time of Update: 2021-07-27
Screenshot source: CDE official websiteAccording to the press release issued by Cinda Biologics, the drug's marketing application in mainland China is based on an open, single-arm, multi-center Phase 2 study, which aims to undergo at least first-line systemic treatment in the past To evaluate the efficacy and safety of pemigatinib in patients with locally advanced, recurrent or metastatic cholangiocarcinoma who have failed, unresectable surgery with FGFR2 fusion or rearrangement .
-
Press conference of the State Council Information Office: Carry out scientific tracing with a scientific attitude
Time of Update: 2021-07-27
Combining the research results of various aspects such as clinical epidemiology, animal and environmental testing, the joint expert group finally determined four possibilities for the emergence of the virus: the direct spillover of zoonotic diseases is "probable to more likely"; introduction through intermediate hosts It is "more likely to very likely"; it is "possible" to introduce it through the cold chain.
-
Pfizer's new crown vaccine caused by delta strain drops to 39%
Time of Update: 2021-07-27
Previous data from the Israeli Ministry of Health showed that from May 2 to June 5, the effective rate of Pfizer's vaccine in preventing new crown infections in Israel was 94.
-
Puli Pharmaceutical Etibatide Injection Obtained Drug Registration Approval
Time of Update: 2021-07-27
On July 25, Puli Pharmaceuticals announced that it had recently received a drug registration approval for eptifibatide injection issued by the State Food and Drug Administration.
It was approved for listing in Europe in July 1999 and is now under the responsibility of GlaxoSmithKline.
-
A new anti-gout drug has exploded!
Time of Update: 2021-07-27
The fastest research and development is Hengrui Medicine's SHR4640 tablets, which is currently undergoing phase III clinical trials in China and is expected to become the first domestically approved Class 1 new drug in the field of anti-gout .
-
New pattern!
Time of Update: 2021-07-27
After the implementation of the policies of "separation of licenses and licenses" and "removal of distance between pharmacies", industry competition has intensified, and ordinary people have benefited, while life in small pharmacies has become even more difficult .
-
China's generic drug development has changed dramatically in the past 6 years
Time of Update: 2021-07-27
Source: PharmaGo The huge market sales have become a driving force for companies to accelerate the completion of the consistency evaluation of generic drugs .
Source: PharmaGo Correspondingly, the number of products approved to pass the consistency evaluation of generic drugs is also increasing .
-
The new crown virus has spread in Europe in October 2019?
Time of Update: 2021-07-27
According to reports, scientists from the Milan Cancer Research Center-the National Cancer Institute (Istituto Nazionale Tumori) wrote in a new paper published on the 19th local time that the two laboratories collected a small amount of blood samples before the outbreak of the new crown epidemic.
-
Zhong Nanshan: Dare to be a doctor
Time of Update: 2021-07-27
" Facing the flag, Chinese Academy of Engineering academician , director of the National Respiratory Disease Clinical Research Center, First Affiliated Hospital of Guangzhou Medical University, Zhong Nanshan solemn oath collar, two new developments in preparation of party members are Wuhan Take the form of remote video to solemnly swear .
-
Anhui starts the collection of cephalexin at the lowest price
Time of Update: 2021-07-27
On July 21, the Anhui Pharmaceutical Joint Procurement Office issued an announcement on the centralized procurement of cephalexin oral normal-release dosage forms .
The announcement clarified that the maximum effective declaration price for this renewal is 0.
Evaluation rules: The lowest price method after evaluation .
-
Health Commission: 48 new confirmed cases on the 22nd, 12 in China
Time of Update: 2021-07-27
As of 24:00 on July 22, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are currently 663 confirmed cases (including 17 severe cases), 87,163 cured and discharged cases, and 4,636 deaths.
-
Zhou Hong, President of Roche Pharmaceuticals China, resigns to Merck's vice president of market access, Bian Xin, to take over
Time of Update: 2021-07-27
At the same time, Merck announced that Zhou Hong will serve as the head of Merck Group Pharmaceutical and Health China and international markets.
-
PIC/S Release Data Reliability Guide (Full text download attached)
Time of Update: 2021-07-27
PIC/S PI 041-1 GOOD PRACTICESFORDATAMANAGEMENT ANDINTEGRITYINREGULATED GMP/GDPENVIRONMENTS Good practices for data management and integrity in a regulated GMP/GDP environment Because the original text is too long, friends who need the full text can download it as follows: Official original download https://picscheme.
-
Multinational pharmaceutical company's semi-annual report: Yang Sen's half-year sales of this drug are $5 billion and Roche's troika suffers
Time of Update: 2021-07-27
From the product point of view, Janssen Usnumab has sales of nearly US$5 billion, with strong growth and is expected to become a super blockbuster; Roche’s “troika” continues to be impacted by biosimilar drugs in H1, with the highest decline of Rituxan Monoclonal antibodies, sales of 1.
-
The National Natural Science Foundation of China announces the list of review teams for key projects in the field of medical science
Time of Update: 2021-07-27
National Natural Science Fund Committee willCommittee member Department of Medical Sciences July 22, 2021
-
So far, no one at the Wuhan Institute of Virology has been infected with the new coronavirus
Time of Update: 2021-07-27
” In response to the issue of the second phase of the virus traceability plan released by the WHO on July 15 Zeng Yixin said, first of all, some rumors about the Wuhan Institute of Virology, "For example, three employees contracted the disease, for example, the Wuhan Institute of Virology carried out the new coronavirus function gain experiment, which is the Gain of function experiment.
-
The joint research report on the traceability of the new coronavirus can withstand the test of history
Time of Update: 2021-07-27
According to Zeng Yixin, deputy director of the National Health Commission, on March 30 this year, the World Health Organization officially released the global traceability study of the new crown virus convened by the World Health Organization: a joint research report on the Chinese part.
-
Experts say the earlier the child's hearing screening diagnostic intervention, the better
Time of Update: 2021-07-27
One organizer, vice Affiliated Central Hospital of Xiamen University, Dean , Department of Otolaryngology Head and Neck Surgery, Professor Cai Chengfu academic leaders in an interview with reporters, said BEIJING, hearing impairment is a common disease, a large number of hearing impaired people: per thousand About 1-3 of the newborns are hearing impaired.
-
The second-stage traceability investigation plan should not violate common sense and science
Time of Update: 2021-07-27
" China-WHO Joint Research Expert on New Coronavirus Traceability Liang Wannian, the Chinese leader of the group, introduced at the press conference that the joint expert group went to Wuhan Virus Institute for a more detailed understanding, communicated with relevant researchers, including relevant management personnel, and inspected the site, especially for its standardization process and management.
-
Retests of blood samples show that the new coronavirus may have spread in Italy
Time of Update: 2021-07-27
In November last year, researchers from the National Cancer Institute of Milan published a paper in the country’s Journal of Oncology, stating that they tested blood samples from 959 volunteers who participated in a lung cancer screening test from September 2019 to March 2020.
